The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Congressionally Directed Medical Research Programs -- Kidney Cancer Research Program -- Early-Career Investigator Award
The KCRP Academy of Kidney Cancer Investigators Award mechanisms, which are being offered for the first time in FY19, support a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty emerging as potential leaders of kidney cancer investigation. The overarching goal of the Academy of Kidney Cancer Investigators (AKCI) is to develop successful, highly productive kidney cancer researchers in a collaborative research and career development environment.
The AKCI will be a virtual career development and research training platform that will consist of Early-Career Investigator (ECI)/Designated Mentor pairs from different institutions, and an Academy Dean. The KCRP AKCIECIA is not a traditional career development award; the ECI is expected to participate in monthly webinars and annual workshops and to communicate and collaborate with other members of the Academy (other ECIs, Mentors, Dean) as well as with the advocacy community.
This FY19 Program Announcement is soliciting ECIs and Designated Mentors to join the inaugural class for the Academy. This award mechanism enables the ECI (the investigator named as the Principal Investigator [PI] on the application) to pursue a kidney cancer project that may be basic, translational, and/or clinical research. The Designated Mentor is not required to be at the same institution as the ECI.
• Required Pre-Application Deadline: Sep. 17, 2019
• Application Submission Deadline: Oct. 1, 2019
Areas of Interest
To be considered for funding, applications for the FY19 PRCRP Career Development Award (CDA) must address at least one of the FY19 PRCRP Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), kidney, melanoma, or ovarian cancer will not be accepted. The FY19 PRCRP Topic Areas are listed below. • Bladder cancer • Blood cancers • Brain cancer • Cancer in children, adolescents, and young adults1 • Colorectal cancer • Immunotherapy2 • Listeria vaccine for cancer • Liver cancer • Lymphoma • Mesothelioma • Neuroblastoma • Pancreatic cancer • Pediatric brain tumors • Rare cancers3 • Stomach cancer
New for FY19: Studies involving melanoma (including rare subtypes of melanoma) should apply to the new FY19 Melanoma Research Program. Studies involving other skin cancers will be accepted by the PRCRP under an appropriate FY19 PRCRP Topic Area (i.e., immunotherapy)
In addition to addressing at least one of the required FY19 PRCRP Topic Areas, applications for the PRCRP Career Development Award must also address at least one of the FY19 PRCRP Military Health Focus Areas. Relevance to military health in medical research focuses on critical issues or gaps in biomedical knowledge that may affect the health and well-being of the military and their beneficiaries.
It is central to the vision and mission of the PRCRP that applications address how the proposed research is related to military health, mission readiness, and cancer health needs of both deployed and non-deployed personnel, their dependents, Veterans, and other military beneficiaries (i.e. family members of retirees). The FY19 PRCRP requires all applications to respond to at least one of the Military Health Focus Areas listed below:
• Environmental/exposure risk factors associated with cancer
• Gaps in cancer prevention, early detection/diagnosis, prognosis, treatment, and/or survivorship that may impact mission readiness and the health and well-being of military members, Veterans, their beneficiaries, and the general public
Early-Career Investigator ○ Must be less than 3 years from his/her last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent as of the full application submission deadline. – A Statement of Eligibility is required with the submission of the full application. ○ Individuals in a postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent, at the time of full application submission deadline are not eligible. ○ May be a research- or physician-scientist. ○ Must not have a concurrent career development-like award at the time of this award. ○ Must commit no less than 25% effort to this award for the first 2 years
Designated Mentor ○ Must be an independent, established kidney cancer researcher. ○ Must have kidney cancer research funding (past and present). ○ Must have a record of kidney cancer publications in peer-reviewed journals. ○ May be at the same institution as the ECI. ○ If not at the same institution, another Mentor (“Other Mentor,” see below) at the ECI’s institution must also be included in the application submission. ○ Must demonstrate a commitment (at least 5% effort for mentoring and participating in Academy activities – offsite meetings and webinars) to develop and sustain the ECI’s independent career in kidney cancer research. ○ Mentoring responsibilities include mentoring the ECI (i.e., the PI of this award) and an additional ECI within the Academy. ○ An AKCI Designated Mentor may serve as a Designated Mentor to only one AKCI-ECI. ○ The Dean of the Academy may not be listed as a Designated Mentor. ○ Off-site Academy activities include annual in-person workshops and monthly web-based meetings.
The anticipated direct costs budgeted for the entire period of performance for an FY19 KCRP AKCIECIA will not exceed $725,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.